Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Courant report: Investor biases lead to significant opportunities for value driven systematic investors

Tuesday, July 09, 2013

Benedicte Gravrand, Opalesque Geneva:

In a new report, Dr. Mel Mullin, CIO of New York-based Courant Capital Management, and his team observe the dynamics of U.S. large-cap equity mispricings that often result from investor behavioral biases. These behaviors often create significant opportunities for value-driven systematic investors.

In the report, entitled "Opportunities From Behavioral Rotations and Dispersion in U.S. Large-Cap Equities," the authors remark that investor biases lead to opportunities for value oriented investors, and that "disciplined participants constructing market neutral portfolios can often take advantage of both sides of mispricing biases, over exuberance and undue pessimism, to accumulate attractive positions ahead of their fundamentally oriented, value-seeking peers."

They found that:

  • Large cap stock investors have rotating lists of favorites and outsiders, which move according to recent news;
  • In most market environments, inefficient pricings from behavioural overreactions tend to correct within three months, as more value-seekers partake and company information is updated;
  • Biased investor behaviors "provide value and profit opportunities for long-only, long/short and market neutral investors;"
  • Systematic market neutral investors focused on U.S. large-cap universe can profit from pricing inefficiencies;
  • Long-only investors usually help restor......................

    To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for